We have qualitatively reviewed this strategy and reaffirmed its Process and People ratings. The team, while experienced, is adjusting after the retirement of a longtime manager. However, the defensive, income-focused process that’s worked well remains intact. The following text is from July 23, 2022.
American Century Equity Income I ACIIX
- NAV / 1-Day Return 8.82 / +1.38 %
- Total Assets 8.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.730%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 5.0 Mil
- Status Open
- TTM Yield 2.56%
- Turnover 29%
USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:15 PM GMT+0
Morningstar’s Analysis ACIIX
Will ACIIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Johnson & Johnson | 4.93 | 419.9 Mil | Healthcare |
Medtronic PLC | 4.62 | 393.5 Mil | Healthcare |
Colgate-Palmolive Co | 2.37 | 201.5 Mil | Consumer Defensive |
Mondelez International Inc Class A | 2.28 | 193.9 Mil | Consumer Defensive |
RTX Corp | 2.26 | 192.2 Mil | Industrials |
Norfolk Southern Corp | 2.22 | 189.3 Mil | Industrials |
Exxon Mobil Corp | 2.16 | 184.1 Mil | Energy |
Becton Dickinson & Co | 2.16 | 184.1 Mil | Healthcare |
PepsiCo Inc | 2.03 | 173.1 Mil | Consumer Defensive |
Roche Holding AG | 2.03 | 173.0 Mil | Healthcare |